首页 | 本学科首页   官方微博 | 高级检索  
     检索      

CELLULAR IMMUNITY EFFECT OF LEUKEMIA VACCINE ON TUMOR BURDEN RAT
作者姓名:赵万红  张王刚  何爱丽  王一理  耿宜萍  田玮  宋长锁
作者单位:Department of Hematology,Department of Hematology,Department of Hematology,Institute of Immunopathology,Institute of Immunopathology,Department of Hematology,Department of Hematology Second Hospital of Xi'an Jiaotong University,Xi'an 710004,China,Second Hospital of Xi'an Jiaotong University,Xi'an 710004,China,Second Hospital of Xi'an Jiaotong University,Xi'an 710004,China,Medical School of Xi’an Jiaotong University,Xi’an 710061,China,Medical School of Xi’an Jiaotong University,Xi’an 710061,China,Second Hospital of Xi'an Jiaotong University,Xi'an 710004,China,Second Hospital of Xi'an Jiaotong University,Xi'an 710004,China
基金项目:ThisworkwassupportedbytheKeyClinicDepartmentDevelopmentItemofChina ,HealthMinistry(No.3 2 0205IM35A)andScientificResearchFoundationoftheSecondHospitalofXi’anJiaotongUniversity(No .2 0 0 0KY 0 4)
摘    要:Atpresent ,chemotherapyisstillimportanttotreatthemalignanthematopoitictumor .Thisthera pyhasnotonlymanysideeffectsbutalsoitssurviv alrateisverylow .Now ,theresearchofactivespe cificimmunotherapyhasbecomearesearchhotspotaftertheprogressofmolecules immunologyandtu mor immunology .Ithasbeenacceptedasanewwaytotreattheleukemiainthe 4 2 ndAmericaHema tologyMeeting .Sotheimmunotherapyofleukemiahasbeenverynoticing .Onthebasisofsometreat menteffectsontreatingsomeleukemia patientswithourleukemiavaccin…


CELLULAR IMMUNITY EFFECT OF LEUKEMIA VACCINE ON TUMOR BURDEN RAT
Zhao Wanhong,Zhang Wanggang,He Aili,Wang Yili ,Geng Yiping ,Tian Wei,Song Changsuo.CELLULAR IMMUNITY EFFECT OF LEUKEMIA VACCINE ON TUMOR BURDEN RAT[J].Academic Journal of Xi’an Jiaotong University,2003,15(1).
Authors:Zhao Wanhong  Zhang Wanggang  He Aili  Wang Yili  Geng Yiping  Tian Wei  Song Changsuo
Institution:1. Department of Hematology , Second Hospital of Xi'an Jiaotong University, Xi'an 710004, China
2. Institute of Immunopathology, Medical School of Xi'an Jiaotong University, Xi'an 710061, China
Abstract:Objective To evaluate the effect of the active specific immunotherapy with leukemia vaccine in the malignant hematopoietic diseases. Methods We established the animal models by inoculating C57BL/6 rats with FBL-3 erythroleukemia cells and prepared three types of tumor vaccine, which were administered on the rats respectively. The MTT colorimetric assay was adopted 2 and 4 weeks later to test the cytotoxicity of macrophage(MΦ) and that of cytotoxic T lymphocyte(CTL) derived from the rats injected with tumor vaccines, and compared the results with the control group. Results With the growth of erythroleulemia cells in the rats, the cellular immunity was seriously depressed, and the inhibition of specific cellular immunity was later than that of non-specific cellular immunity. The tumor vaccine made from inactivated tumor cells, IFA and cytokines (rGM-CSF, rIL-2 and rIL-6), promote the cellular immunity of tumor burden rats, especially the specific cellular immunity more efficiently than that of tumor vaccine made from inactivated tumor cells and IFA, but the third vaccine made from inactivated tumor cells alone has no effect. Conclusion The tumor vaccine made from inactivated tumor cells with addition of IFA and cytokines (rGM-CSF, rIL-2 and rIL-6) provides a promising future in the active specific immunotherapy against hematopoietic tumor.
Keywords:active specific immunotherapy  leukemia  tumor vaccine  macrophage  cytotoxicity T lymphocyte
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号